{
  "zip": "SO16 6YD",
  "sector": "Healthcare",
  "fullTimeEmployees": 14,
  "longBusinessSummary": "Synairgen plc discovers and develops drugs for respiratory diseases. It develops inhaled interferon beta (IFN-Ã), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-Ã that is in Phase-II clinical trial for the treatment or prevention of chronic obstructive pulmonary disease exacerbations caused by the common cold and flu; and LOXL2 inhibitor, which has completed Phase I clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF) and non-alcoholic fatty liver diseases. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor; and a strategic collaboration with Parexel Biotech on pivotal Phase III trial for the study of inhaled COVID-19 treatment. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.",
  "city": "Southampton",
  "phone": "44 23 8051 2800",
  "country": "United Kingdom",
  "companyOfficers": [],
  "website": "http://www.synairgen.com",
  "maxAge": 1,
  "address1": "Mailpoint 810",
  "fax": "44 23 8051 2800",
  "industry": "Biotechnology",
  "address2": "Level F, South Block Southampton General Hospital Tremona Road",
  "previousClose": 2.43,
  "regularMarketOpen": 2.37,
  "twoHundredDayAverage": 2.172375,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 2.37,
  "navPrice": null,
  "averageDailyVolume10Day": 31837,
  "totalAssets": null,
  "regularMarketPreviousClose": 2.43,
  "fiftyDayAverage": 2.172375,
  "trailingAnnualDividendRate": null,
  "open": 2.37,
  "averageVolume10days": 31837,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": -3.268641,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 2.18,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 42830,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 436865664,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 31837,
  "priceToSalesTrailing12Months": null,
  "dayLow": 2.18,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 42830,
  "fiftyTwoWeekHigh": 2.49,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 1.87,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 2.37,
  "exchange": "PNK",
  "shortName": "SYNAIRGEN",
  "longName": "Synairgen plc",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "SYGGF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_20361040",
  "uuid": "67aad190-4088-3bf3-94d8-e0f30fb11076",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 199914000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.20822,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.03018,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 143775892,
  "enterpriseValue": 348179904,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 2.37,
  "logo_url": "https://logo.clearbit.com/synairgen.com"
}